Pharmaids Pharmaceuticals Q2 FY27 Results: Net Loss of ₹1.8 Cr, Loss Narrows
Pharmaids Pharmaceuticals Ltd reported revenue from operations of ₹4.3 Cr (-50.0% YoY) and a net loss of ₹1.8 Cr for Q2 FY27.
- Key figure
- Net loss ₹1.8 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Pharmaids Pharmaceuticals Ltd reported revenue from operations of ₹4.3 Cr (-50.0% YoY) and a net loss of ₹1.8 Cr for Q2 FY27.
Pharmaids Pharmaceuticals Ltd reported revenue from operations of ₹4.1 Cr (-38.8% YoY) and net profit of ₹1.9 Cr (-64.2% YoY) for Q1 FY27.
Pharmaids Pharmaceuticals Ltd reported revenue from operations of ₹7.2 Cr (+50.0% YoY) and a net loss of ₹1.1 Cr for Q4 FY26.
Pharmaids Pharmaceuticals reported audited FY26 results and approved a ₹0.75 Crore corporate guarantee for its subsidiary. Performance details and subsidiary support reflect ongoing operational strategy.